NeuPath Health Inc. filed its Annual on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 CAD | -.--% | +8.33% | +5.41% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.41% | 8.05M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-1.41% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt